Cardiovascular Surgery
World's Thinnest Absorbable Stent
MOTIV, made from the patented polymer Tyrocore™, supports vessel healing and maintains patency with its superior radial strength and thin structure. Not only is it the first biodegradable stent to receive CE mark approval, but it has also been granted Breakthrough Device Status by the FDA in the United States. MOTIV reduces risks and, over time, completely dissolves, allowing the vessel to regain its natural mobility. In clinical trials, positive outcomes such as 90% vessel patency and 97% limb preservation rate have been achieved during a 6-month follow-up period. With these features, MOTIV offers a promising treatment option for patients.
